What volume of whole blood should be removed during therapeutic phlebotomy for polycythemia?

Therapeutic Phlebotomy Volume for Polycythemia

For therapeutic phlebotomy in polycythemia, remove 350-500 mL of whole blood per session, performed every 2-3 days until the target hematocrit is achieved.

Standard Volume Protocols

The volume removed depends on the patient's total blood volume and clinical status:

• Standard volume: 350-500 mL of whole blood per procedure 1, 2
• Fixed protocol: 350 mL every 3 days has been shown effective and safe in achieving target hematocrit 1
• Alternative approach: 10% of total blood volume can be removed in a single session 3
• Large volume: Up to 600 mL may be removed based on patient's total blood volume, though 500 mL is most commonly used 1, 2

Target Hematocrit Goals

The therapeutic endpoint is critical for determining frequency and duration:

• Polycythemia vera: Maintain hematocrit <45% 4
• Secondary polycythemia: Target hematocrit of approximately 52% 1
• Female patients: Consider lower target of 42% in some cases 4

Procedure Timing and Frequency

• Interval between procedures: Every 2-3 days until target hematocrit achieved 1
• Duration: Each procedure takes 15-30 minutes 2
• Pre-surgical preparation: Control hematocrit for 3 months before elective surgery, with additional phlebotomy as needed to maintain hematocrit <45% 4

Advanced Technique: Double Red-Cell Phlebotomy

An automated approach removes more red cell mass per session:

• Volume removed: 360-420 mL of pure red blood cells (not whole blood) 5
• Effectiveness: Reduces hematocrit by 6.9% compared to 3.0% with conventional whole blood phlebotomy 5
• Advantage: More efficient red cell mass reduction with less total blood volume removed 5
• Limitation: Higher rate of mild adverse events (32.5% vs 4.2%) 5

Clinical Outcomes

The fixed volume protocol demonstrates:

• Hemoglobin reduction: Mean decline from 17.84 g/dL to 14.67 g/dL 1
• Hematocrit reduction: Decrease from 57.11% to 46.27% 1
• Symptomatic improvement: Significant amelioration of clinical parameters on visual analogue scale 1
• Subjective benefit: Majority of patients report clinical improvement, particularly those with higher baseline hematocrit 3

Important Caveats

• Access requirements: Use large-bore needle for adequate flow 2
• Iron depletion: Expect significant decline in serum iron (from 132.85 μg/dL to 69.41 μg/dL) as therapeutic endpoint is reached 1
• Monitoring: Check complete blood count before and after each procedure 1
• Pregnancy considerations: Maintain hematocrit <45% throughout pregnancy using phlebotomy as needed 4